dsm-firmenich is strategically focusing on enhancing its position in the nutrition, health, and beauty sectors through mergers and operational synergies while separating its Animal Nutrition & Health business to optimize profitability.
Information on the Target
dsm-firmenich, a leader in nutrition, health, and beauty, has achieved strong performance in the first half of 2025, characterized by organic sales and earnings growth. The company is effectively executing its strategic plan, which emphasizes the integration of its capabilities to deliver comprehensive cost and revenue synergies following its recent merger.
With a robust portfolio and a global operational footprint, dsm-firmenich is well-positioned amidst the current uncertain macroeconomic environment. The company continues to innovate, focusing on growth driven by its unique solutions in consumer products.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The nutrition and health industry in the European market has been experiencing notable growth, fueled by increased consumer demand for wellness-oriented products. As people become more health-conscious, the ind
Similar Deals
Novonesis
invested in
Feed Enzymes Alliance
in 2025
in a Buyout deal
Disclosed details
Transaction Size: $1,619M
EBITDA: $2,540M